CNS Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.

CEO

John M. Climaco

CEOJohn M. Climaco

Employees

Employees5

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

2017

Founded2017

Employees

Employees5

CNSP Key Statistics

Market cap

3.36M

Market cap3.36M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

53.45K

Average volume53.45K

High today

$2.60

High today$2.60

Low today

$2.39

Low today$2.39

Open price

$2.60

Open price$2.60

Volume

57.68K

Volume57.68K

52 Week high

$41.40

52 Week high$41.40

52 Week low

$2.39

52 Week low$2.39

CNSP Earnings

-$0.16

-$0.11

-$0.05

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 2, Pre-Market

ActualExpected Mar 2, Pre-Market

CNS Pharmaceuticals

Why Robinhood?

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. Show more

CNSP Key Statistics

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.